Page last updated: 2024-10-20

purine and ALS - Amyotrophic Lateral Sclerosis

purine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.

Research Excerpts

ExcerptRelevanceReference
"Amyotrophic lateral sclerosis (ALS), Lou Gehrig's disease, is a progressive fatal neurodegenerative disease that involves both upper and lower motor neurons."5.43New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway. ( Kato, M; Kato, S; Kusano, T; Nishino, T, 2016)
"Amyotrophic lateral sclerosis (ALS), Lou Gehrig's disease, is a progressive fatal neurodegenerative disease that involves both upper and lower motor neurons."1.43New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway. ( Kato, M; Kato, S; Kusano, T; Nishino, T, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kato, S1
Kato, M1
Kusano, T1
Nishino, T1

Other Studies

1 other study available for purine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway.
    Journal of neuropathology and experimental neurology, 2016, 12-01, Volume: 75, Issue:12

    Topics: Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Enzyme Inhibitors

2016